| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.61▲ | 2.59▲ | 2.49▲ | 2.62▼ | 2.36▲ |
| MA10 | 2.60▲ | 2.49▲ | 2.44▲ | 2.57▲ | 1.75▲ |
| MA20 | 2.57▲ | 2.45▲ | 2.52▲ | 2.30▲ | 1.42▲ |
| MA50 | 2.45▲ | 2.60▲ | 2.60▲ | 1.60▲ | 1.32▲ |
| MA100 | 2.44▲ | 2.59▲ | 2.40▲ | 1.35▲ | 1.51▲ |
| MA200 | 2.54▲ | 2.38▲ | 1.92▲ | 1.23▲ | 2.58▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.039▲ | 0.015▲ | -0.011▼ | 0.180▲ |
| RSI | 73.638▲ | 62.776▲ | 56.308▲ | 66.875▲ | 80.404▲ |
| STOCH | 87.419▲ | 96.162▲ | 57.528 | 65.542 | 84.797▲ |
| WILL %R | -6.667▲ | -1.538▲ | -1.538▲ | -33.152 | -15.229▲ |
| CCI | 87.407 | 120.730▲ | 118.357▲ | 24.293 | 119.591▲ |
|
Wednesday, December 03, 2025 01:17 PM
Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that ...
|
|
Friday, November 28, 2025 08:37 AM
Alto Neuroscience, Inc.'s innovative approach to CNS disorder treatment and 2026 clinical milestones. Click here to find out why ANRO stock is a Buy.
|
|
Friday, November 21, 2025 12:17 PM
Palo Alto Networks (NASDAQ: PANW) created a buying opportunity for investors with its fiscal Q1 (calendar Q3) results. The results included outperformance and improved guidance, along with plans for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 09/12/25 | 2.31 | 2.62 | 2.295 | 2.615 | 1,230,072 |
| 08/12/25 | 2.51 | 2.56 | 2.33 | 2.37 | 1,749,000 |
| 05/12/25 | 2.81 | 2.88 | 2.47 | 2.51 | 1,613,900 |
| 04/12/25 | 2.84 | 2.92 | 2.75 | 2.79 | 1,510,900 |
| 03/12/25 | 2.50 | 2.83 | 2.50 | 2.80 | 1,628,300 |
| 02/12/25 | 2.64 | 2.65 | 2.48 | 2.56 | 1,708,300 |
| 01/12/25 | 2.53 | 2.72 | 2.47 | 2.63 | 1,362,100 |
| 28/11/25 | 2.45 | 2.57 | 2.42 | 2.55 | 588,900 |
| 26/11/25 | 2.49 | 2.62 | 2.35 | 2.45 | 2,021,000 |
| 25/11/25 | 2.15 | 2.52 | 2.11 | 2.45 | 2,548,600 |
|
|
||||
|
|
||||
|
|